When we followed a cohort of users managing weekly GLP-1 therapy for several months, the pattern became clear: people who escalated the dose slowly often reported steadier appetite control with fewer abrupt rebounds, while those who moved up faster or missed weeks reported more variable weeks and greater confusion about what to expect
The open field test took place on the morning of day 9, followed by the elevated plus maze test in the afternoon
A 2024 study in Japan of semaglutide users, measured over multiple years, concluded that getting enough sleep may improve the weight loss effect of GLP-1 RAs in real-world settings. Moreover, with regard to improvements in sleep duration or quality for semaglutide users, its the outcome of the medicine itselfweight lossthat can really move the needle
As an excitatory neurotransmitter, glutamate is imperative for learning, attention, and focus but too much glutamate causes too much stimulation in the brain
A A Pract
Understanding how Ozempic and retatrutide fit into this landscape helps contextualize the options available today
